| Net Loss Per Share |
8. Net Loss Per Share Net loss per share The following table sets forth the computation of the basic and diluted net loss per share for the three and six months ended June 30, 2025 and 2024 (in thousands, except share and per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
|
Six Months Ended
June 30, |
|
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(17,643 |
) |
|
$ |
(27,663 |
) |
|
$ |
(34,808 |
) |
|
$ |
(58,184 |
) |
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares of common stock |
|
|
16,524,324 |
|
|
|
4,358,345 |
|
|
|
16,512,580 |
|
|
|
4,343,527 |
|
Weighted average pre-funded warrants to purchase common stock |
|
|
10,425,428 |
|
|
|
500,000 |
|
|
|
10,425,428 |
|
` |
|
500,000 |
|
Weighted-average shares used to compute net loss per share, basic and diluted |
|
|
26,949,752 |
|
|
|
4,858,345 |
|
|
|
26,938,008 |
|
|
|
4,843,527 |
|
Net loss per share, basic and diluted |
|
$ |
(0.65 |
) |
|
$ |
(5.69 |
) |
|
$ |
(1.29 |
) |
|
$ |
(12.01 |
) |
Potential dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows:
|
|
|
|
|
|
|
|
|
|
|
As of June 30, |
|
|
|
2025 |
|
|
2024 |
|
Stock options issued and outstanding under the 2019 Plan and 2015 Stock Plan |
|
|
3,391,339 |
|
|
|
698,651 |
|
Estimated shares issuable under the Amended ESPP |
|
|
10,261 |
|
|
|
1,617 |
|
Total |
|
|
3,401,600 |
|
|
|
700,268 |
|
|